Healthpeak Properties (DOC) Projected to Post Earnings on Thursday

Key Points

• Healthpeak Properties (DOC) is set to report Q1 2026 results after the close on April 23, with analysts projecting EPS of $0.0597 and revenue of $685.6M, and management has given FY2026 EPS guidance of $1.70–$1.74.
• The company announced a monthly dividend of $0.1017 per share (record/ex-dividend date June 15, pay date June 26), implying a 7.1% yield
• Shares opened at $17.20 with a market cap of $11.96B and an average analyst price target of $19.19; analysts are mixed (six Buy, eight Hold), and the company last beat estimates with $0.47 EPS on $719.4M revenue.

Healthpeak Properties (NYSE:DOC - Get Free Report) will likely be releasing its Q1 2026 results after the market closes on Thursday, April 23rd. Analysts expect Healthpeak Properties to post earnings of $0.0597 per share and revenue of $685.5810 million for the quarter. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. Interested persons may visit the the company's upcoming Q1 2026 earning results page for the latest details on the call scheduled for Wednesday, May 6, 2026 at 10:00 AM ET.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its quarterly earnings data on Monday, February 2nd. The real estate investment trust reported $0.47 EPS for the quarter, topping analysts' consensus estimates of $0.45 by $0.02. The firm had revenue of $719.40 million during the quarter, compared to analyst estimates of $685.14 million. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The company's revenue for the quarter was up 3.1% on a year-over-year basis. During the same period in the previous year, the company posted $0.46 EPS. On average, analysts expect Healthpeak Properties to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Healthpeak Properties Stock Performance

Shares of DOC opened at $17.20 on Thursday. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.82 and a current ratio of 2.82. The stock has a 50 day moving average price of $17.02 and a two-hundred day moving average price of $17.34. The firm has a market capitalization of $11.96 billion, a P/E ratio of 171.98, a P/E/G ratio of 9.03 and a beta of 1.10. Healthpeak Properties has a 52 week low of $15.71 and a 52 week high of $19.68.

Healthpeak Properties Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 15th will be issued a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a yield of 7.1%. The ex-dividend date of this dividend is Monday, June 15th. Healthpeak Properties's payout ratio is currently 1,220.00%.

Hedge Funds Weigh In On Healthpeak Properties

Hedge funds and other institutional investors have recently modified their holdings of the business. Advocate Investing Services LLC purchased a new position in shares of Healthpeak Properties in the 4th quarter worth approximately $26,000. CYBER HORNET ETFs LLC purchased a new position in shares of Healthpeak Properties in the 2nd quarter worth approximately $33,000. Wiser Advisor Group LLC purchased a new position in shares of Healthpeak Properties in the 3rd quarter worth approximately $38,000. DV Equities LLC purchased a new position in shares of Healthpeak Properties in the 4th quarter worth approximately $36,000. Finally, Los Angeles Capital Management LLC purchased a new position in shares of Healthpeak Properties in the 4th quarter worth approximately $55,000. Hedge funds and other institutional investors own 93.57% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on DOC. Robert W. Baird decreased their price objective on Healthpeak Properties from $20.00 to $19.00 and set an "outperform" rating for the company in a report on Monday, April 6th. Argus lowered Healthpeak Properties from a "buy" rating to a "hold" rating in a report on Thursday, February 5th. Evercore decreased their price objective on Healthpeak Properties from $21.00 to $19.00 and set an "outperform" rating for the company in a report on Wednesday, February 4th. Wells Fargo & Company reissued a "positive" rating on shares of Healthpeak Properties in a report on Tuesday, February 3rd. Finally, Wall Street Zen upgraded Healthpeak Properties from a "sell" rating to a "hold" rating in a research note on Saturday, April 11th. Six equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. According to MarketBeat.com, Healthpeak Properties presently has an average rating of "Hold" and an average price target of $19.19.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.